Biopta
ビオプタAlias
Ticker
—
Listed market
—
Country
Employees (non-consolidated)
—
Related companies
4
§01
Basic information
- Head office
- 未記載
- Chief executive
- 未記載
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- 2003-02-01
- End date
§02
Websites
§03
Business
GMP-grade iMSC & MSC productionStem Cell ReagentsCellsStem Cell Products3D Cell CultureLabwareClinical-grade stem cell servicesGene editing servicesGenomic & bioinformatics servicesGMP iPSC & iMSC MCB manufacturingGMP manufacturing facilityiPSC-derived exosome production serviceRegenerative medicine productsCustom research stem cell servicesDonor recruitmentCustom reprogrammingExpansion & characterizationGenomic servicesNucleic acid extractionReal-time PCRBiomarker discovery and validationNext-Generation SequencingOligonucleotide Synthesis ServiceNeoantigen Detection ServiceCellular ServicesCentral Lab ServicesBiomarker ServicesMolecular ServicesProject ManagementCells and products for stem cell research and 3D cell cultureRNA ReprogrammingSmall MoleculesGene Editing ProductsStemfactor Growth Factors and CytokinesQkine Growth Factors and CytokinesAntibodies and Staining KitsStem Cell Culture MediaCell SubstratesCryopreservation MediaDissociation SolutionsTransfection ReagentsStemRNA Induced Pluripotent Stem Cells (iPSCs)StemEdit Gene Edited iPSCsDifferentiated iPSCs and Related ReagentsMesenchymal Stem Cells (MSCs)Immortalized Cell Lines and Related ReagentsFeeder CellsiPSC-derived ExosomesAlvetex 3D Cell Culture SystemsAlvetex Advanced Tissue Bioengineering SystemEZSPHERE Multiwell Dishes and PlatesKOKEN Atelocollagen (AteloCell)ABLE Biott Bioreactor SystemsBioThrust Bioreactor Systems2mag Stirring SystemsDistributors of REPROCELL Products Worldwidecontract research services in human /drug-efficacy-safety-admeex vivo living tissues /drug-efficacy-safety-admeclinical trials for neurodegenerative disease treatmentsdiagnostic services and clinical research servicesDevelopment and commercialization of culture media for human ES/iPS cellsProduction of cardiomyocytes derived from human iPS cellsProduction of neurons derived from human iPS cellsStem cell-based drug development support technologiesResearch and development in regenerative medicine and tailor-made medicineUse of human fresh tissues3D modelsUse of iPSCs to characterize drug efficacy and inter-patient variabilityPredictive drug discovery servicesBioengineered tissue model servicesStem cell research productsiPSC-derived human cardiomyocytes, hepatocytes, and neuronal cells3D cell culture and bioengineered tissuesdrug discoveryclinical MSC and MSC-derived ATMPs CDMO servicesNIPT clinical servicesPCR testing services for COVID-19personal iPS servicecGMP suite for iPSC-derived glial progenitorsCRISPR/Cas9 genome editing servicesLaboratory services for drug discoveryBiomarker and genetic discovery collaborationStem cell therapy technologyDevelopment and sale of human iPSC-derived cell modelsCustom-made disease model cellsCell therapy development servicesStem cell research servicesDiagnostic development servicesPreclinical drug development servicesClinical drug development servicesStem cell reagentsStem cell products3D cell culture products
§04
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
Names without a link are companies not yet registered in OpenBizGraph
§05
Network
Drag to move · click to open
§06
History
§07
News
There is no news.
§09
Sources & updates
DOMAINOwn domain:Yes
UPDATED2026-10-02 19:07 · Model: gpt-4.1-nano